Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Boehringer Ingelheim

Last Updated: January 28, 2020

DrugPatentWatch Database Preview

Hospira Inc Company Profile

See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for HOSPIRA INC, and what generic and branded alternatives to HOSPIRA INC drugs are available?

HOSPIRA INC has eighty-seven approved drugs.

There are five tentative approvals on HOSPIRA INC drugs.

Summary for Hospira Inc

Drugs and US Patents for Hospira Inc

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hospira Inc THEOPHYLLINE IN DEXTROSE 5% IN PLASTIC CONTAINER theophylline INJECTABLE;INJECTION 019211-004 Dec 14, 1984 DISCN No No   Start Trial   Start Trial
Hospira Inc SODIUM BICARBONATE sodium bicarbonate INJECTABLE;INJECTION 202981-001 Mar 4, 2016 AP RX No No   Start Trial   Start Trial
Hospira Inc CEFTRIAXONE ceftriaxone sodium INJECTABLE;INTRAMUSCULAR, INTRAVENOUS 065230-003 Aug 2, 2005 AP RX No No   Start Trial   Start Trial
Hospira Inc AMPICILLIN SODIUM ampicillin sodium INJECTABLE;INJECTION 202865-001 Sep 4, 2015 DISCN No No   Start Trial   Start Trial
Hospira Inc HYDROMORPHONE HYDROCHLORIDE hydromorphone hydrochloride INJECTABLE;INJECTION 200403-001 Dec 1, 2011 AP RX No No   Start Trial   Start Trial
Hospira Inc PHYSIOSOL PH 7.4 IN PLASTIC CONTAINER magnesium chloride; potassium chloride; sodium acetate; sodium chloride; sodium gluconate SOLUTION;IRRIGATION 018406-002 Jul 8, 1982 DISCN No No   Start Trial   Start Trial
Hospira Inc HEPARIN SODIUM heparin sodium INJECTABLE;INJECTION 090571-001 Aug 31, 2009 AP RX No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Paragraph IV (Patent) Challenges for HOSPIRA INC drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Injection 1 mg/mL, 50 mL vials ➤ Subscribe 2011-12-16
➤ Subscribe Injection 100 mg/mL, 2.5 mL vials ➤ Subscribe 2007-09-24
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.